A cuff that squeezes the leg might save muscle in ICU patients

NCT ID NCT07802743

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This trial tests a rehabilitation technique called blood flow restriction training (BFRT) in adults on ventilators who develop ICU-acquired weakness, a condition of severe muscle loss. BFRT uses an inflatable cuff on the upper leg to partially restrict blood flow during low-intensity exercise, aiming to build muscle with less effort than traditional training. Researchers will randomly assign 120 patients to standard care alone, or standard care plus BFRT at one of two pressure levels, for two weeks. They will measure muscle strength, muscle size, blood inflammation markers, and recovery times to see if BFRT helps and which pressure works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Blood flow restriction training (BFRT) using an inflatable cuff on the upper leg during low-intensity exercise
What this could lead to
If it works, this could offer a safe way to help critically ill patients on ventilators preserve muscle and recover faster, potentially shortening hospital stays.
What could go wrong
This is an early-stage trial with a modest number of patients, and results may not apply to all ICU settings. The cuff could cause discomfort or circulation issues, and the optimal pressure is still unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥ 18 years; 2. Received invasive mechanical ventilation for ≥ 48 hours; 3. Meets the clinical diagnosis criteria for ICUAW: The patient has reached a level of consciousness that allows for reliable assessment of voluntary muscle strength, is able to execute standardized motor commands, has an MRC-SS \< 48 points, and has no other clearly identifiable cause that explains the muscle weakness; 4. RASS score of -1 to 0, and is able to cooperate with the prescribed muscle strength assessment and rehabilitation training; 5. Current vital signs and respiratory and circulatory status are stable, meeting the safety conditions for rehabilitation training, as assessed by clinical physicians and rehabilitation therapists; 6. The patient or their legal representative has signed the informed consent form, voluntarily participating in the study. Exclusion Criteria: 1. The presence of pre-existing central or peripheral nervous system diseases, neuromuscular diseases, or severe motor function disorders that significantly affect limb strength or motor function prior to ICU admission; 2. The presence of active deep vein thrombosis, pulmonary embolism, significant peripheral arterial disease, limb ischemia, or other severe lower limb vascular diseases; 3. Severe coagulation function abnormalities, active bleeding, or a clinically judged unacceptable risk of thrombosis/hemorrhage; 4. The presence of fractures, open wounds, local infections, significant skin damage, or other conditions in the target lower limb that are unsuitable for cuff compression and exercise training; 5. Recent acute coronary syndrome, decompensated heart failure, uncontrolled severe arrhythmias, or other active cardiovascular diseases that are unsuitable for BFRT; 6. Instability in respiratory or circulatory status at the time of screening, or the need for new or significantly increased use of vasoactive drugs, failing to meet the safety criteria for rehabilitation training; such individuals may be rescreened after their condition stabilizes; 7. Anticipation of imminent death, or a decision to limit or withdraw life support treatment; 8. Allergy to the cuff material, or the circumference of the target limb is not compatible with the cuff being used; 9. Inability to reliably complete specified assessments such as MRC-SS after adequate arousal.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intensive care unit acquired weakness are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.